It has been suggested that cancer registries in England are too dependent on the processing of information from death certificates ([@bib3]; [@bib10]; [@bib1]; [@bib8]). This could have several adverse effects: (a) case ascertainment would be incomplete, particularly for non-fatal cases; (b) survival time would be too short, because hospital activity related to recurrent disease or end-of-life care would sometimes be recorded as the first known event and hence provide the date of diagnosis. A further consequence of these errors would be that (c) reported cancer survival statistics for England would be estimated with a systematic bias and be too low.

Cancer registries in England have recently linked routine cancer registration records with information from the Hospital Episode Statistics (HES) database (<http://www.hesonline.nhs.uk>). The HES database contains details of all in-patient and day-case admissions to National Health Service (NHS) hospitals in England.

The linked data set provides a new opportunity to evaluate the magnitude of errors (a), (b), and (c), defined above. Based on record linkage with the HES database, records missing in the cancer register were identified, and dates of diagnosis were revised. The effects of those revisions on the estimated survival time and proportion of patients surviving for 1 year or more were studied. Cases that were absent in the cancer register and present in the HES data with a relevant diagnosis code and a relevant surgery code were used to estimate (a) the completeness of the cancer register. Differences in survival times calculated from the two data sources were used to estimate (b) the possible extent of error in the recorded survival time in the cancer register. Finally, we combined (a) and (b) to estimate (c) the resulting differences in 1-year cumulative survival estimates.

The analyses presented here were executed at the Thames Cancer Registry on behalf of cancer registries in England, in order to address the comments in a recent editorial by [@bib1]. The principal analysis and the form of reporting of findings were specified before we had any knowledge of the results of the investigation.

Materials and methods
=====================

We identified all cancer records in the HES-only side of the linked data set that in 2001--2007 had activity relating to colorectal cancer (ICD10 C18--C21), lung cancer (C33--C34), or breast cancer (C50), and that had a surgery code indicating a relevant, non-diagnostic surgical procedure. By HES-only cases, we are referring to the cases identified by the record linkage, that are not present in the cancer register but present in the HES data with a relevant diagnosis code and a relevant surgery code. These cases would not be included in routine cancer survival analysis, and they represent good-prognosis cases that may have been missed in the primary case ascertainment in the cancer registries, and not subsequently identified through routine record linkage with death certificates.

The three cancer diagnosis groups were selected to represent the spectrum of fatality among different, common types of cancer. The HES-only records were considered as an indication of the possible magnitude of under-ascertainment of non-fatal cancer cases in the cancer registries.

We considered only surgically treated cases because the combination of diagnosis code and resection code in the HES record gives a high degree of certainty that the record represents a true record of cancer. The HES-only records without an indication of cancer treatment would not be considered as sufficient evidence to create a cancer registration, and would need to be verified against other clinical records. The large majority of such HES-only records are known to relate to cases where cancer might have been suspected but it was not subsequently confirmed ([@bib2]).

To give a measure of incompleteness, we compared the number of HES-only records (with surgical treatment) against the number of regular cancer registration records in the linked data set, and stratified this analysis by sex, age, year of diagnosis or HES activity (2001--2007), and cancer registry. We plotted the incompleteness measure for each cancer registry for each year.

To evaluate the possible magnitude of survival time error, we identified all cases in the cancer registry records with a recorded survival time of \<1 year. These rapidly fatal cases were considered as the ones most likely to be influenced by a systematic survival time error. Within the three groups of cancers, we searched the HES records for evidence of an earlier cancer diagnosis for these persons (with or without a record of surgery), and used the first matching HES record with a relevant diagnosis code. We computed the difference in survival time (days) using the two alternative dates of diagnosis. We described the distributions of the survival time difference, stratified by type of cancer, and cancer registry.

Finally, we evaluated the likely magnitude of the influence of incompleteness and survival time error on a commonly used outcome measure: the 1-year survival proportion. We computed 1-year survival in three ways: (i) as routinely reported by cancer registries, (ii) with account taken of the HES-only cases and their respective 1-year survival, and (iii) with further account taken of the extent of possible survival time error in the cancer registration records.

Results
=======

[Table 1](#tbl1){ref-type="table"} shows the estimated incompleteness of case ascertainment. The HES-only cases added 1.9% to the number of colorectal cancer registrations, 0.4% to lung cancer, and 2.0% to breast cancer. These effects were similar in males and females, slightly higher in the younger age groups, and declined over the period 2001--2007. There was some variation between cancer registries, with the highest incompleteness in the Thames Cancer Registry (4.1% in colorectal cancer, 0.5% in lung cancer, and 4.3% in breast cancer) and lowest in the Trent and the South West registries. There was a general decrease in incompleteness over time in most cancer registries ([Figure 1](#fig1){ref-type="fig"}). [Table 2](#tbl2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"} show the analysis of survival time error. The distribution of the difference between the two computed survival times (survival time according to HES data (HES-derived) *minus* survival time according to the cancer registry (registry-derived)) was extremely skewed. For colorectal cancer and lung cancer, 5.1% and 4.7% (respectively) of cases had a difference of \>1 month, and 0.8% and 0.4% (respectively) had a difference of \>1 year. [Figures 2A and B](#fig2){ref-type="fig"} show that the registries had similar cumulative distributions after about 3 months (i.e., the proportions of registrations with a difference of \>3 months were similar across the registries). The North West cancer registry had a higher proportion of cases with a survival time difference of \>1 month.

For breast cancer, 6.2% of cases had a survival time difference of more than 1 month and 2.7% differed by \>1 year. There was variation in the distributions between the cancer registries, which persisted for \>1 year ([Figure 2C](#fig2){ref-type="fig"}). The proportion of cases with survival difference of \>1 year ranged from 0.8% in Northern and Yorkshire to 4.4% in Trent.

[Table 3](#tbl3){ref-type="table"} shows the three alternative analyses of 1-year survival. The 1-year survival estimates increased when the HES-only cases and their respective survival times were considered in the analysis. The changes were small, amounting to 0.5, 0.2, and 0.2 percentage points for colorectal, lung, and breast cancer, respectively. With the further use of the HES-derived survival times for the cancer registration records, the 1-year survival times increased further but the changes remained small: 1.0, 0.8, and 0.4 percentage points, respectively.

Discussion
==========

The main findings from this analysis are that completeness of case ascertainment in English cancer registries is high, possibly as much as 98--99%, when evaluated against independently recorded hospital episodes which included relevant cancer diagnosis and surgery codes. The analysis found evidence of the hypothesised survival time error. Around 5--6% of rapidly fatal (1 year) cancer registrations had the survival time extended by more than a month and up to 3% of rapidly fatal breast cancer records were extended by more than a year. However, the resulting impact on estimates of 1-year survival was small, up to one percentage point for colorectal cancer. There was some variation in completeness and survival time difference between cancer registries.

There are important limitations of this analysis, and we do not propose that it gives a full and accurate estimation of completeness and survival time errors. The analysis uses a new source of data and a pre-specified analysis plan to indicate the possible magnitude and impact of the errors and biases proposed by [@bib1] and previously investigated and discussed by ourselves ([@bib3]; [@bib10]; [@bib7], [@bib8]). We decided *a priori* to consider only resected cases from HES as potentially missed cases in cancer registration, these would be representatives of the non-fatal cancers that the registration process might have missed ([@bib3]). The most likely reason for any absence of surgical treatment of hospitalised cancer patients would be that they were too ill to be considered eligible for surgery. The exclusion of such patients as potential cases is not likely to result in artificial underestimation of survival, but rather the contrary.

A small proportion of cancer patients may have had their diagnosis and surgery services provided in private hospitals, particularly patients residing in the London area. Such patients are not all recorded in the cancer registries and treatment services provided on a private basis are not recorded in HES.

The analysis suggests a slightly lower completeness in the youngest age groups, that is, colorectal and lung cancer patients below 50 years and breast cancer patients below 35 years ([Table 1](#tbl1){ref-type="table"}). This observation is based on small numbers. The good prognosis of young patients may be a contributing factor to this.

The principal limitation of the study lies in the completeness of the record linkage with the HES data and the accuracy of the information therein. Unique person identifiers (NHS numbers) have come to be almost universally used in NHS hospitals only in the last few years, and this puts a limit on the period covered in the linked data set. The year-on-year improvement in the availability of NHS numbers and in the completeness of the record linkage is the most likely reason for the slightly lower estimated completeness in 2001 and 2002 for colorectal cancer and breast cancer ([Table 1](#tbl1){ref-type="table"}).

Even in the most recent period, the linkage algorithm used NHS number, sex, date of birth, postcode, and date of death, and it is known to be imperfect. Some of the apparent HES-only cases will in fact have a corresponding record in the cancer registry, and there may be duplication whereby more than one of the HES-only cases relates to a single person.

Additionally, there are known errors in the routine HES data (as in any administrative data set) and some cases will have been missed because they did not include the specific cancer diagnosis or a relevant surgery code. We are not able to determine the direction and magnitude of errors created by these imperfections, but it seems unlikely that our analysis is severely flawed or biased. We will continue to explore means of quality assurance and improvement of the cancer registry records. The new linked data set will gradually improve through quality assurance processes related to the continuous use of the data and its annual updating.

Taken at face value, the 1--4% incompleteness in the Thames Cancer Registry is about as we would expect from previous analyses ([@bib3]; [@bib10]) and a recent update thereof (unpublished data, available on request). It is reassuring that most registries seem to have even higher completeness than Thames. The analysis of survival time differences between HES and cancer registries serves as a sensitivity analysis of survival estimates derived from English cancer registry data, but it should not be inferred that the earlier diagnosis date from HES is the correct one, particularly when the difference is small. The date of diagnosis concept in cancer registration does not always take the date of first hospital activity or first clinical diagnosis. In many cases, the date (often later) of the definitive histopathological diagnosis will prevail, in accordance with the international definition of date of diagnosis. The observed distribution of survival time differences in the North West cancer registry could be due to a more rigorous application of this rule, and does not necessarily point to a particular problem in the processing of death certificate information. The differences we have found between cancer registries will be explored by the registries and used in their continued quality assurance and improvement of the service.

In conclusion, we confirm the hypothesis ([@bib1]) -- and our own expectations ([@bib3]; [@bib10]; [@bib8]) -- that incompleteness of case ascertainment and survival time error are real phenomena which bias cancer survival estimates in the direction of too low estimates. The error is very small compared with the observed differences between North West European countries ([@bib7], [@bib8]) and between socioeconomic groups in England ([@bib9]). Although the British situation, with immediate availability and processing of information from death certificates, entails a risk of dependence on this source of information, this is more desirable than the situation in several other European countries where death information can only be processed with technical difficulty and delay, or where it is considered as sensitive and not available for cancer registration ([@bib7]). The estimates of completeness in cancer registries in England are generally consistent with estimates from other national cancer registries that process information from death certificates in the primary case ascertainment, for example, Finland ([@bib10]) and Norway ([@bib5]).

In the mid-1990s, the Thames Cancer Registry had 15--20% registrations based entirely on death certificates, and the data would not at present be considered as suitable for cancer survival analysis. This death certificate-only proportion has been gradually reduced to 1.6% in 2008. English cancer registration data can no longer be simply dismissed as unfit-for-purpose. It is worth noting that the errors we have discussed are not specific to the British situation but will exist in the same form or in similar forms in other countries as well. The best strategy is to be careful in the selection of comparison countries and to retain a critical (and self-critical) attitude to the international cancer survival and cancer mortality comparisons we perform ([@bib4]; [@bib8]; [@bib6]).

This paper is a contribution from the National Cancer Intelligence Network and is based on the information collected and quality assured by the regional cancer registries in England (<http://www.ukacr.org>; <http://www.ncin.org.uk>). The Thames Cancer Registry in King\'s College London receives funding from the Department of Health for England. The views expressed in the article are those of the authors and not necessarily those of the Department of Health.
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###### Completeness of case ascertainment in cancer registries in England, 2001--2007, evaluated with HES records containing both a relevant diagnosis code and a relevant code for non-diagnostic surgery

                                                                 **Colorectal cancer**   **Lung cancer**   **Breast cancer**                                         
  ------------------------------------------------------------- ----------------------- ----------------- ------------------- ----- --------- ----- ------ --------- -----
  Total                                                                  4027                206 794              1.9          802   219 483   0.4   4921   251 201   2.0
                                                                                                                                                                        
  *Sex*                                                                                                                                                              
   Male                                                                  2050                111 787              1.8          458   128 881   0.4    37     1797     2.1
   Female                                                                1948                95 007               2.1          344   90 602    0.4   4881   249 404   2.0
   NA                                                                     29                    0                               0       0             3        0        
                                                                                                                                                                        
  *Age (years)*                                                                                                                                                         
   0--4                                                                    0                    3                               0       7             0        1        
   5--9                                                                    0                    1                               0       3             0        0        
   10--14                                                                  4                   21                               0       8             1        1        
   15--19                                                                  9                   79                               4      26             15      14        
   20--24                                                                 15                   249                              3      37             17      125       
   25--29                                                                 16                   374                              5      94             40      874     4.6
   30--34                                                                 28                   670                4.2          10      238            82     3317     2.5
   35--39                                                                 48                  1447                3.3          14      614           191     8398     2.3
   40--44                                                                 80                  2842                2.8          27     1722     1.6   290    15 257    1.9
   45--49                                                                 117                 4949                2.4          43     3992     1.1   416    20 787    2.0
   50--54                                                                 172                 8770                2.0          43     8660     0.5   509    29 098    1.7
   55--59                                                                 302                15 613               1.9          111   16 463    0.7   587    31 710    1.9
   60--64                                                                 398                20 368               2.0          119   23 762    0.5   625    30 317    2.1
   65--69                                                                 512                26 795               1.9          117   30 799    0.4   583    27 210    2.1
   70--74                                                                 643                32 600               2.0          153   38 454    0.4   484    22 559    2.1
   75--79                                                                 698                35 483               2.0          111   41 973    0.3   502    22 167    2.3
   80--84                                                                 553                30 667               1.8          33    31 891    0.1   332    19 093    1.7
   85+                                                                    387                25 863               1.5           7    20 740    0.0   234    20 273    1.2
   NA                                                                     45                    0                               2       0             13       0        
                                                                                                                                                                        
  *Year*                                                                                                                                                             
   2001                                                                   751                28 329               2.7          139   31 141    0.4   865    34 352    2.5
   2002                                                                   705                28 410               2.5          122   30 512    0.4   867    34 223    2.5
   2003                                                                   546                28 787               1.9          101   30 757    0.3   637    36 261    1.8
   2004                                                                   535                29 575               1.8          95    31 161    0.3   654    36 182    1.8
   2005                                                                   435                30 167               1.4          107   31 684    0.3   567    36 990    1.5
   2006                                                                   513                30 627               1.7          120   32 425    0.4   650    36 803    1.8
   2007                                                                   542                30 899               1.8          118   31 803    0.4   681    36 390    1.9
                                                                                                                                                                        
  *Registry*                                                                                                                                                         
   Eastern Cancer Registration & Information Centre (ECRIC)               527                23 232               2.3          106   21 396    0.5   722    28 501    2.5
   North west Cancer Intelligence Service                                 533                27 881               1.9          111   35 384    0.3   562    32 831    1.7
   Northern & Yorkshire Cancer Registry & Information Service             317                29 769               1.1          85    37 541    0.2   325    32 904    1.0
   Oxford Cancer Intelligence Unit                                        134                10 220               1.3          54     9081     0.6   185    13 835    1.3
   South west Cancer Intelligence Service                                 290                32 726               0.9          87    27 780    0.3   298    39 368    0.8
   Thames Cancer Registry                                                1639                39 740               4.1          204   42 236    0.5   2224   51 915    4.3
   Trent Cancer Registry                                                  165                20 448               0.8          43    23 310    0.2   214    24 693    0.9
   West Midlands Cancer Intelligence Unit                                 359                22 778               1.6          105   22 755    0.5   355    27 154    1.3
   NA                                                                     63                    0                               7       0             36       0        

Abbreviations: HESO=Hospital Episode Statistics (HES)-only records from the linked repository (version 2007) with a surgery code for 'major surgery\' H/R=HESO/REPO expressed as a percentage, computed for numerators \>20 cases; NCIN=National Cancer Intelligence Network; REPO=valid cancer registrations from the linked repository. (These exclude the HESO records).

Analysis based on first occurrences of the particular type of cancer in a person.

Major surgery is defined as in the forthcoming NCIN surgery report. The definitions are available.

###### Difference in survival time from date of diagnosis in cancer registration and from earliest episode in HES, England 2001--2007

                                                                **Survival difference**             **Proportion that changed (%)**                           
  ------------------------------------------------------------- ------------------------- --------- --------------------------------- --------- ------ ------ -----
  *Colorectal cancer registry*                                                                                                                                 
   Eastern Cancer Registration & Information Centre (ECRIC)     4207                      7134      7390                              7460      56.4   4.4    0.9
   North West Cancer Intelligence Service                       5362                      8652      9643                              9729      55.1   11.1   0.9
   Northern & Yorkshire Cancer Registry & Information Service   6366                      9581      9730                              9750      65.3   1.7    0.2
   Oxford Cancer Intelligence Unit                              2041                      3142      3235                              3244      62.9   3.1    0.3
   South West Cancer Intelligence Service                       7431                      10 110    10 459                            10 563    70.3   4.3    1.0
   Thames Cancer Registry                                       8668                      13 075    13 669                            13 859    62.5   5.7    1.4
   Trent cancer registry                                        4799                      6993      7221                              7284      65.9   4.0    0.9
   West Midlands Cancer Intelligence Unit                       4448                      7374      7711                              7756      57.3   4.9    0.6
   Total                                                        43 322                    66 061    69 058                            69 645    62.2   5.1    0.8
                                                                                                                                                               
  *Lung cancer registry*                                                                                                                                       
   Eastern Cancer Registration & Information Centre (ECRIC)     10 627                    15 534    16 004                            16 045    66.2   3.2    0.3
   North West Cancer Intelligence Service                       17 740                    23 860    26 910                            27 094    65.5   11.9   0.7
   Northern & Yorkshire Cancer Registry & Information Service   20 316                    27 565    27 956                            27 996    72.6   1.5    0.1
   Oxford Cancer Intelligence Unit                              5008                      6769      6920                              6931      72.3   2.3    0.2
   South West Cancer Intelligence Service                       15 843                    20 318    20 978                            21 079    75.2   3.6    0.5
   Thames Cancer Registry                                       22 258                    30 237    31 365                            31 536    70.6   4.1    0.5
   Trent Cancer Registry                                        13 096                    17 106    17 554                            17 634    74.3   3.0    0.5
   West Midlands Cancer Intelligence Unit                       11 193                    16 652    17 430                            17 484    64.0   4.8    0.3
   Total                                                        116 081                   158 041   165 117                           165 799   70.0   4.7    0.4
                                                                                                                                                               
  *Breast cancer registry*                                                                                                                                     
   Eastern Cancer Registration & Information Centre (ECRIC)     1801                      2183      2238                              2287      78.7   4.5    2.1
   North West Cancer Intelligence Service                       2113                      2847      3037                              3141      67.3   9.4    3.3
   Northern & Yorkshire Cancer Registry & Information Service   2002                      2422      2462                              2481      80.7   2.4    0.8
   Oxford Cancer Intelligence Unit                              900                       1020      1030                              1040      86.5   1.9    1.0
   South West Cancer Intelligence Service                       3194                      3592      3719                              3821      83.6   6.0    2.7
   Thames Cancer Registry                                       3684                      4383      4588                              4768      77.3   8.1    3.8
   Trent Cancer Registry                                        2112                      2472      2569                              2687      78.6   8.0    4.4
   West Midlands Cancer Intelligence Unit                       1838                      2250      2313                              2347      78.3   4.1    1.4
   Total                                                        17 644                    21 169    21 956                            22 572    78.2   6.2    2.7

All cases died within 1 year from diagnosis according to the cancer registry record.

###### Case numbers and deaths within 1 year according to cancer registry data and HES data, and impact on one-year survival estimates, England, 2001--2007

                       **Case numbers**   **One-year survival estimate (%)**                                            
  ------------------- ------------------ ------------------------------------ --------- ----- --------- ------- ------- -------
                              A                           B                       C       D       E      \(1\)   \(2\)   \(3\)
  Colorectal cancer        206 794                       4027                  69 645    353   68 654    66.3    66.8    67.3
  Lung cancer              219 483                       802                   165 799   46    164 485   24.5    24.7    25.3
  Breast cancer            251 201                       4921                  22 572    82    21 858    91.0    91.2    91.4

Abbreviation: HES=Hospital Episode Statistics.

A: as reported in [Table 1](#tbl1){ref-type="table"} on completeness of case ascertainment; B: as reported in [Table 1](#tbl1){ref-type="table"} on completeness of case ascertainment; C: these cases died within 1 year according to the cancer registry data; D: these HES-only cases died within 1 year according to the HES data; E: with date of diagnosis revised, some registry cases now survive longer than 1 year.

(1)=(A--C)/A; (2)=((A+B)--(C+D))/(A+B); (3)=((A+B)--(E+D))/(A+B).
